A Russian medical journal has published data from early clinical trials of the country's second COVID-19 vaccine. It finds that the jab is safe and effective, but critics say there are still many unanswered questions. Julia Chapman has more.
IN: The medical journal...
OUT: SOC
DUR: 0:45
http://www.fsnradionews.com/feeds/0325EpiVacCorona-jc.mp3
IN: The medical journal...
OUT: SOC
DUR: 0:45
http://www.fsnradionews.com/feeds/0325EpiVacCorona-jc.mp3